OMCL 32.24 Omnicell Inc $OMCL Hit a 52 week high of 32.54 Closing the day 11/03/14 at 32.24 -0.07 -0.22% With a day low of 31.76 and a total volume of 256,127.
OMCL Recent Posts: http://investorshangout.com/Omnicell-OMCL-54976/
OMCL Omnicell Inc Recent Headline News
Omnicell Gains Despite Earnings Miss; View Up on High Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 10:20AM CST
Omnicell's (OMCL) share prices have climbed 7.3% since the earnings release to close at $32.31 on Friday
AMSG: 52.41 (-1.60), USPH: 43.27 (+0.12), RDNT: 9.53 (+0.23), OMCL: 32.24 (-0.07)
Omnicell misses 3Q profit forecasts
Automated Insights - Thu Oct 30, 6:37PM CDT
MOUNTAIN VIEW, Calif. (AP) _ Omnicell Inc. (OMCL) on Thursday reported profit of $7.3 million in its third quarter.
OMCL: 32.24 (-0.07)
Omnicell Announces Third Quarter 2014 Results
PR Newswire - Thu Oct 30, 3:01PM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for its third quarter ended September 30, 2014.
OMCL: 32.24 (-0.07)
Global Pharmacy Automation Systems Market Forecasts and Opportunities, 2019 - Analysis of the $4.1 Billion Industry
M2 - Tue Oct 28, 6:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zh84wk/pharmacy) has announced the addition of the "Pharmacy Automation Systems Market by product type & by End-user - Global Forecasts & Trends to 2019" report to their offering. The pharmacy automation market is expected to reach $4.5 billion by 2019 from $3.1 billion in 2014 The global pharmacy automation systems market has witnessed considerable growth over the past few years and is further expected to grow In this report the market is segmented by product, end user, and by geography. On the basis of product, the market includes automated medication dispensing systems, automated packaging and labeling systems, automated medication compounding systems, storage and retrieval systems, table-top counters, and other systems. Whereas, on the basis of end users, the market includes the inpatient pharmacy units, outpatient pharmacy units, retail pharmacies, and pharmacy benefit management organizations and other mail-order setting. The inpatient pharmacy automation market is further classified as acute care setting and long-term care setting, while the outpatient pharmacy automation market is segmented into fast-track clinics and hospital pharmacies. Factors such as the necessity of cost containment, reduction of medication errors, and the need to increase the efficiency of work within the pharmacies are the major drivers for the pharmacy automation systems market. However, stringent regulatory guidelines which delay product launches, high costs of implementation of automation systems, and restricted budgets of healthcare that lower investments in the automated systems by small companies are some of the key factors restraining the growth of the global market. However, the increasing awareness regarding the benefits of the pharmacy automation systems in the developing countries offer new growth opportunities to the market players. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Pharmacy Automation Systems Market, By Product 5 Global Pharmacy Automation Systems Market, By End-Users 6 Global Pharmacy Automation Systems Market, By Geography 7 Competitive Landscape 8 Company Profiles - Baxter International Inc. - Carefusion Corporation - Cerner Corporation - Kirby Lester - Mckesson Corporation - Omnicell, Inc. - Parata Systems Llc - Scriptpro Llc - Swisslog Holding Ag - Talyst, Inc. For more information visit http://www.researchandmarkets.com/research/zh84wk/pharmacy
BAX: 69.68 (-0.46), OMCL: 32.24 (-0.07), CERN: 63.26 (-0.08)
Wake Forest Baptist Medical Center Will Convert to Omnicell Medication Automation Solutions
PR Newswire - Mon Oct 27, 7:00AM CDT
Omnicell, Inc., (NASDAQ:OMCL), today announced that Wake Forest Baptist Medical Center, located in Winston-Salem, North Carolina, has selected the Company's pharmacy, nursing and data analytics solutions to drive workflow efficiencies that improve patient care. Omnicell's Unity enterprise platform will support the academic medical center with automated medication management solutions driven by pharmacists and used by nurses and other clinicians caring for patients across the health system's three hospitals. Installation will begin in 2015.
OMCL: 32.24 (-0.07)
Today's Strong And Under The Radar Stock Is Omnicell (OMCL)
at The Street - Fri Oct 24, 2:00PM CDT
Trade-Ideas LLC identified Omnicell (OMCL) as a strong and under the radar candidate
OMCL: 32.24 (-0.07)
Quality Systems Misses on Q2 Fiscal Earnings by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 12:30PM CDT
Quality Systems' (QSII) revenues at the end of the quarter stood at $120.5 million, representing an increase of 8.5% from the year-ago revenues.
PACB: 6.56 (unch), QSII: 14.84 (-0.27), ANGO: 16.99 (-0.01), OMCL: 32.24 (-0.07)
Omnicell to Release Third Quarter 2014 Earnings Results on October 30
PR Newswire - Thu Oct 23, 7:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Thursday, October 30, to discuss the Company's Third Quarter 2014 financial results.
OMCL: 32.24 (-0.07)
athenahealth Q3 Earnings Fall but Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 9:30AM CDT
For the full year 2014, athenahealth (ATHN) reiterated its revenues guidance of $725 to $755 million
ZLTQ: 25.71 (+0.07), GWPH: 74.11 (+0.36), OMCL: 32.24 (-0.07), ATHN: 123.65 (+1.15)
Global Medication Management Market 2014-2019 - Systems, Services & Mode of Delivery Analysis of the $1.6 Billion Industry
M2 - Mon Oct 20, 5:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9vjmrp/medication) has announced the addition of the "Medication Management Market by Systems, Services, Mode of Delivery - Global Forecast to 2019" report to their offering. The global medication management market is valued at an estimated $845.1 million in 2014 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach $1,624.9 million by 2019 The adoption of medication management solutions by healthcare providers is increasing, owing to the rising concerns for minimizing adverse drug events and related medication errors. This is one of the key factors driving the growth of this market in the forecast period. Government initiatives to improve quality of care for patients and reduce healthcare expenditure are also expected to support the growth of the market in the coming years. The global market is broadly segmented by systems, services, mode of delivery, and end-users. The software market is divided into computerized physician order entry, clinical decision support systems, administration software, inventory management software, automated dispensing systems, and assurance systems software. The market, by services, is divided into medication analytics, point-of-care verification, and ADE (adverse drug events) surveillance. The end-users market is segmented into hospitals, pharmacies, and others. The market, by mode of delivery, is divided into on-premises, web-based, and cloud-based models. In 2013, the North American market dominated the global medication management market with a share of 63.7%, followed by Europe, APAC, and RoW. The APAC region shows the maximum growth potential in the coming few years. The urgent need for modernization of healthcare infrastructure, owing to the growth in aging population and increasing incidences of chronic diseases will help drive this market. Countries such as South Korea, China, and Singapore are expected to steer the growth of the medication management market in the APAC region. CareFusion Corporation (U.S.), McKesson Corporation (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), Cerner Corporation (U.S.), and Siemens Healthcare (Germany) are some of the top players in the global medication management market. Report Scope By Software - Computerized Physician Order Entry - Clinical Decision Support System - Administration Software - Electronic Medication Administration Record (EMAR) - Barcode Medication Administration (BMA) - Inventory Management - Automated Dispensing Systems (ADS) - Centralized - Robots - Carousels - Decentralized Automated Dispensing Systems - Pharmacy-based ADS - Ward-based ADS - Automated Unit-Dose Dispensing - Assurance System Software By Services - Medication Analytics - Point-of-Care Verification - ADE Surveillance By End-users - Hospitals - Pharmacy - Others By Mode of Delivery - On-premises - Web-based - Cloud-based Companies Mentioned - Allscripts Healthcare Solutions, Inc. - Carefusion Corporation - Cerner Corporation - GE Healthcare (A Division Of General Electric Company) - Mckesson Corporation - Meditech - Omnicell, Inc. - Optum Inc. - Quadramed Corporation - Siemens Healthcare (Subsidiary Of Siemens Ag) For more information visit http://www.researchandmarkets.com/research/9vjmrp/medication
GE: 25.70 (-0.11), MCK: 203.39 (-0.02), MDRX: 13.80 (+0.08), OMCL: 32.24 (-0.07), CERN: 63.26 (-0.08)
Allscripts Healthcare Solutions EHR Attains Full KLAS Rating - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 03, 12:40PM CDT
According to KLAS's August 2014 report, Allscripts Healthcare Solutions, Inc.'s (MDRX) Sunrise Ambulatory Care has been deemed to be the most highly-rated EHR across four categories.
ATEC: 1.53 (+0.01), MDRX: 13.80 (+0.08), OMCL: 32.24 (-0.07), CERN: 63.26 (-0.08)
Pharmacy Automation Systems Market Segment Upto 2018: Transparency Market Research
PRWeb - Tue Sep 30, 8:18AM CDT
Pharmacy automation systems benefit hospitals and pharmacies in ways that can best be described as effective and error-free. As demand grows across the globe, there are immense opportunities for vendors in the global pharmacy automation systems market.
OMCL: 32.24 (-0.07)
Allscripts Healthcare Solutions Partners with Citra Health - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 29, 4:59PM CDT
The partnership between Allscripts Healthcare Solutions, Inc. (MDRX) and Citra Health aims to help practices, provider organizations and payers succeed with emerging value-based care and reimbursement models.
MDRX: 13.80 (+0.08), MRGE: 2.86 (+0.11), OMCL: 32.24 (-0.07), CERN: 63.26 (-0.08)
First Patients Enrolled in Landmark Clinical Study to Evaluate the Role of Packaging in Improving Medication Adherence
PR Newswire - Thu Sep 25, 7:00AM CDT
Omnicell® Inc. today announced the commencement of the STOMPP (Study the Effect of a Hybrid Pharmacy Practice Model on Medication Adherence) clinical study. The evaluation is led by Dr. Sharrel Pinto, Division Head and Associate Professor in the Health Outcomes and Socioeconomic Sciences Division and Research Director of the Center for Pharmaceutical Care and Outcomes Research at The University of Toledo College of Pharmacy and Pharmaceutical Sciences.
OMCL: 32.24 (-0.07)
athenahealth Expands Operations in Georgia and California - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 2:00PM CDT
The move is a part of athenahealth's (ATHN) growth strategy across the U.S. through which the company will multiply its foothold in major health care technology markets to meet varied client needs.
MRGE: 2.86 (+0.11), OMCL: 32.24 (-0.07), CERN: 63.26 (-0.08), ATHN: 123.65 (+1.15)
Cerner Gets Regulatory Go-Ahead for Siemens AG Unit Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 12:10PM CDT
On Aug 5, Cerner Corporation (CERN) revealed its plans to acquire Siemens Health Services for a whopping $1.3 billion in cash.
ATEC: 1.53 (+0.01), MRGE: 2.86 (+0.11), OMCL: 32.24 (-0.07), CERN: 63.26 (-0.08)
athenahealth Up to Buy on High EHR Adoption - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 19, 4:50PM CDT
For fiscal 2014, athenahealth, Inc. (ATHN) saw two estimates move north over the last 60 days causing the Zacks Consensus Estimate to move up 8.0% to its current level of 27 cents.
ATEC: 1.53 (+0.01), MRGE: 2.86 (+0.11), OMCL: 32.24 (-0.07), ATHN: 123.65 (+1.15)
Allscripts Healthcare Solutions' dbMotion Gets New Client - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 17, 6:05PM CDT
Flagler Hospital has chosen Allscripts Healthcare Solutions (MDRX) dbMotion due to its population health analytics capabilities and the feature of an EHR agent.
MDRX: 13.80 (+0.08), MRGE: 2.86 (+0.11), OMCL: 32.24 (-0.07), ATHN: 123.65 (+1.15)
Is Merge Healthcare (MRGE) a Buy post Solid Q2 Results? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 10, 2:10PM CDT
On Sep 9, 2014, we issued an updated research report on Merge Healthcare Incorporated (MRGE).
MCK: 203.39 (-0.02), ABAX: 52.95 (+0.29), MRGE: 2.86 (+0.11), OMCL: 32.24 (-0.07)
Align Partners Zimmer Dental on iTero Intraoral Scanner - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 09, 4:50PM CDT
Recently, Align Technology, Inc. (ALGN) entered into a partnership with Carlsbad, CA-based Zimmer Dental, Inc.
MCK: 203.39 (-0.02), ALGN: 51.81 (-0.81), ABAX: 52.95 (+0.29), OMCL: 32.24 (-0.07)
OMCL Recent Posts: http://investorshangout.com/Omnicell-OMCL-54976/
OMCL Omnicell Inc Recent Headline News
Omnicell Gains Despite Earnings Miss; View Up on High Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 10:20AM CST
Omnicell's (OMCL) share prices have climbed 7.3% since the earnings release to close at $32.31 on Friday
AMSG: 52.41 (-1.60), USPH: 43.27 (+0.12), RDNT: 9.53 (+0.23), OMCL: 32.24 (-0.07)
Omnicell misses 3Q profit forecasts
Automated Insights - Thu Oct 30, 6:37PM CDT
MOUNTAIN VIEW, Calif. (AP) _ Omnicell Inc. (OMCL) on Thursday reported profit of $7.3 million in its third quarter.
OMCL: 32.24 (-0.07)
Omnicell Announces Third Quarter 2014 Results
PR Newswire - Thu Oct 30, 3:01PM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for its third quarter ended September 30, 2014.
OMCL: 32.24 (-0.07)
Global Pharmacy Automation Systems Market Forecasts and Opportunities, 2019 - Analysis of the $4.1 Billion Industry
M2 - Tue Oct 28, 6:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zh84wk/pharmacy) has announced the addition of the "Pharmacy Automation Systems Market by product type & by End-user - Global Forecasts & Trends to 2019" report to their offering. The pharmacy automation market is expected to reach $4.5 billion by 2019 from $3.1 billion in 2014 The global pharmacy automation systems market has witnessed considerable growth over the past few years and is further expected to grow In this report the market is segmented by product, end user, and by geography. On the basis of product, the market includes automated medication dispensing systems, automated packaging and labeling systems, automated medication compounding systems, storage and retrieval systems, table-top counters, and other systems. Whereas, on the basis of end users, the market includes the inpatient pharmacy units, outpatient pharmacy units, retail pharmacies, and pharmacy benefit management organizations and other mail-order setting. The inpatient pharmacy automation market is further classified as acute care setting and long-term care setting, while the outpatient pharmacy automation market is segmented into fast-track clinics and hospital pharmacies. Factors such as the necessity of cost containment, reduction of medication errors, and the need to increase the efficiency of work within the pharmacies are the major drivers for the pharmacy automation systems market. However, stringent regulatory guidelines which delay product launches, high costs of implementation of automation systems, and restricted budgets of healthcare that lower investments in the automated systems by small companies are some of the key factors restraining the growth of the global market. However, the increasing awareness regarding the benefits of the pharmacy automation systems in the developing countries offer new growth opportunities to the market players. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Pharmacy Automation Systems Market, By Product 5 Global Pharmacy Automation Systems Market, By End-Users 6 Global Pharmacy Automation Systems Market, By Geography 7 Competitive Landscape 8 Company Profiles - Baxter International Inc. - Carefusion Corporation - Cerner Corporation - Kirby Lester - Mckesson Corporation - Omnicell, Inc. - Parata Systems Llc - Scriptpro Llc - Swisslog Holding Ag - Talyst, Inc. For more information visit http://www.researchandmarkets.com/research/zh84wk/pharmacy
BAX: 69.68 (-0.46), OMCL: 32.24 (-0.07), CERN: 63.26 (-0.08)
Wake Forest Baptist Medical Center Will Convert to Omnicell Medication Automation Solutions
PR Newswire - Mon Oct 27, 7:00AM CDT
Omnicell, Inc., (NASDAQ:OMCL), today announced that Wake Forest Baptist Medical Center, located in Winston-Salem, North Carolina, has selected the Company's pharmacy, nursing and data analytics solutions to drive workflow efficiencies that improve patient care. Omnicell's Unity enterprise platform will support the academic medical center with automated medication management solutions driven by pharmacists and used by nurses and other clinicians caring for patients across the health system's three hospitals. Installation will begin in 2015.
OMCL: 32.24 (-0.07)
Today's Strong And Under The Radar Stock Is Omnicell (OMCL)
at The Street - Fri Oct 24, 2:00PM CDT
Trade-Ideas LLC identified Omnicell (OMCL) as a strong and under the radar candidate
OMCL: 32.24 (-0.07)
Quality Systems Misses on Q2 Fiscal Earnings by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 12:30PM CDT
Quality Systems' (QSII) revenues at the end of the quarter stood at $120.5 million, representing an increase of 8.5% from the year-ago revenues.
PACB: 6.56 (unch), QSII: 14.84 (-0.27), ANGO: 16.99 (-0.01), OMCL: 32.24 (-0.07)
Omnicell to Release Third Quarter 2014 Earnings Results on October 30
PR Newswire - Thu Oct 23, 7:00AM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Thursday, October 30, to discuss the Company's Third Quarter 2014 financial results.
OMCL: 32.24 (-0.07)
athenahealth Q3 Earnings Fall but Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 9:30AM CDT
For the full year 2014, athenahealth (ATHN) reiterated its revenues guidance of $725 to $755 million
ZLTQ: 25.71 (+0.07), GWPH: 74.11 (+0.36), OMCL: 32.24 (-0.07), ATHN: 123.65 (+1.15)
Global Medication Management Market 2014-2019 - Systems, Services & Mode of Delivery Analysis of the $1.6 Billion Industry
M2 - Mon Oct 20, 5:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9vjmrp/medication) has announced the addition of the "Medication Management Market by Systems, Services, Mode of Delivery - Global Forecast to 2019" report to their offering. The global medication management market is valued at an estimated $845.1 million in 2014 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach $1,624.9 million by 2019 The adoption of medication management solutions by healthcare providers is increasing, owing to the rising concerns for minimizing adverse drug events and related medication errors. This is one of the key factors driving the growth of this market in the forecast period. Government initiatives to improve quality of care for patients and reduce healthcare expenditure are also expected to support the growth of the market in the coming years. The global market is broadly segmented by systems, services, mode of delivery, and end-users. The software market is divided into computerized physician order entry, clinical decision support systems, administration software, inventory management software, automated dispensing systems, and assurance systems software. The market, by services, is divided into medication analytics, point-of-care verification, and ADE (adverse drug events) surveillance. The end-users market is segmented into hospitals, pharmacies, and others. The market, by mode of delivery, is divided into on-premises, web-based, and cloud-based models. In 2013, the North American market dominated the global medication management market with a share of 63.7%, followed by Europe, APAC, and RoW. The APAC region shows the maximum growth potential in the coming few years. The urgent need for modernization of healthcare infrastructure, owing to the growth in aging population and increasing incidences of chronic diseases will help drive this market. Countries such as South Korea, China, and Singapore are expected to steer the growth of the medication management market in the APAC region. CareFusion Corporation (U.S.), McKesson Corporation (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), Cerner Corporation (U.S.), and Siemens Healthcare (Germany) are some of the top players in the global medication management market. Report Scope By Software - Computerized Physician Order Entry - Clinical Decision Support System - Administration Software - Electronic Medication Administration Record (EMAR) - Barcode Medication Administration (BMA) - Inventory Management - Automated Dispensing Systems (ADS) - Centralized - Robots - Carousels - Decentralized Automated Dispensing Systems - Pharmacy-based ADS - Ward-based ADS - Automated Unit-Dose Dispensing - Assurance System Software By Services - Medication Analytics - Point-of-Care Verification - ADE Surveillance By End-users - Hospitals - Pharmacy - Others By Mode of Delivery - On-premises - Web-based - Cloud-based Companies Mentioned - Allscripts Healthcare Solutions, Inc. - Carefusion Corporation - Cerner Corporation - GE Healthcare (A Division Of General Electric Company) - Mckesson Corporation - Meditech - Omnicell, Inc. - Optum Inc. - Quadramed Corporation - Siemens Healthcare (Subsidiary Of Siemens Ag) For more information visit http://www.researchandmarkets.com/research/9vjmrp/medication
GE: 25.70 (-0.11), MCK: 203.39 (-0.02), MDRX: 13.80 (+0.08), OMCL: 32.24 (-0.07), CERN: 63.26 (-0.08)
Allscripts Healthcare Solutions EHR Attains Full KLAS Rating - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 03, 12:40PM CDT
According to KLAS's August 2014 report, Allscripts Healthcare Solutions, Inc.'s (MDRX) Sunrise Ambulatory Care has been deemed to be the most highly-rated EHR across four categories.
ATEC: 1.53 (+0.01), MDRX: 13.80 (+0.08), OMCL: 32.24 (-0.07), CERN: 63.26 (-0.08)
Pharmacy Automation Systems Market Segment Upto 2018: Transparency Market Research
PRWeb - Tue Sep 30, 8:18AM CDT
Pharmacy automation systems benefit hospitals and pharmacies in ways that can best be described as effective and error-free. As demand grows across the globe, there are immense opportunities for vendors in the global pharmacy automation systems market.
OMCL: 32.24 (-0.07)
Allscripts Healthcare Solutions Partners with Citra Health - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 29, 4:59PM CDT
The partnership between Allscripts Healthcare Solutions, Inc. (MDRX) and Citra Health aims to help practices, provider organizations and payers succeed with emerging value-based care and reimbursement models.
MDRX: 13.80 (+0.08), MRGE: 2.86 (+0.11), OMCL: 32.24 (-0.07), CERN: 63.26 (-0.08)
First Patients Enrolled in Landmark Clinical Study to Evaluate the Role of Packaging in Improving Medication Adherence
PR Newswire - Thu Sep 25, 7:00AM CDT
Omnicell® Inc. today announced the commencement of the STOMPP (Study the Effect of a Hybrid Pharmacy Practice Model on Medication Adherence) clinical study. The evaluation is led by Dr. Sharrel Pinto, Division Head and Associate Professor in the Health Outcomes and Socioeconomic Sciences Division and Research Director of the Center for Pharmaceutical Care and Outcomes Research at The University of Toledo College of Pharmacy and Pharmaceutical Sciences.
OMCL: 32.24 (-0.07)
athenahealth Expands Operations in Georgia and California - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 2:00PM CDT
The move is a part of athenahealth's (ATHN) growth strategy across the U.S. through which the company will multiply its foothold in major health care technology markets to meet varied client needs.
MRGE: 2.86 (+0.11), OMCL: 32.24 (-0.07), CERN: 63.26 (-0.08), ATHN: 123.65 (+1.15)
Cerner Gets Regulatory Go-Ahead for Siemens AG Unit Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 12:10PM CDT
On Aug 5, Cerner Corporation (CERN) revealed its plans to acquire Siemens Health Services for a whopping $1.3 billion in cash.
ATEC: 1.53 (+0.01), MRGE: 2.86 (+0.11), OMCL: 32.24 (-0.07), CERN: 63.26 (-0.08)
athenahealth Up to Buy on High EHR Adoption - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 19, 4:50PM CDT
For fiscal 2014, athenahealth, Inc. (ATHN) saw two estimates move north over the last 60 days causing the Zacks Consensus Estimate to move up 8.0% to its current level of 27 cents.
ATEC: 1.53 (+0.01), MRGE: 2.86 (+0.11), OMCL: 32.24 (-0.07), ATHN: 123.65 (+1.15)
Allscripts Healthcare Solutions' dbMotion Gets New Client - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 17, 6:05PM CDT
Flagler Hospital has chosen Allscripts Healthcare Solutions (MDRX) dbMotion due to its population health analytics capabilities and the feature of an EHR agent.
MDRX: 13.80 (+0.08), MRGE: 2.86 (+0.11), OMCL: 32.24 (-0.07), ATHN: 123.65 (+1.15)
Is Merge Healthcare (MRGE) a Buy post Solid Q2 Results? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 10, 2:10PM CDT
On Sep 9, 2014, we issued an updated research report on Merge Healthcare Incorporated (MRGE).
MCK: 203.39 (-0.02), ABAX: 52.95 (+0.29), MRGE: 2.86 (+0.11), OMCL: 32.24 (-0.07)
Align Partners Zimmer Dental on iTero Intraoral Scanner - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 09, 4:50PM CDT
Recently, Align Technology, Inc. (ALGN) entered into a partnership with Carlsbad, CA-based Zimmer Dental, Inc.
MCK: 203.39 (-0.02), ALGN: 51.81 (-0.81), ABAX: 52.95 (+0.29), OMCL: 32.24 (-0.07)
